Catalent behind Novo Nordisk's supply issues, says media

An FDA inspection gone awry at contract manufacturer Catalent's Belgian facility is allegedly behind Novo Nordisk's supply issues for its obesity drug, Wegovy, which was recently launched on the US market.

Concerns about acceptable production practices at Catalent's syringe filling facility is the reason why Novo Nordisk is now only expected to be able to fully meet Wegovy demand in the second half of 2022, according to media Bioprocess International.

Catalent confirms that an inspection by the US Food and Drug Administration (FDA) resulted in an FDA Form 483, which is issued to a firm's management following an inspection during which objectionable conditions have been observed.

Read the whole article

Get 14 days free access.

No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Coloplast upgrades growth expectations following acquisition

Medtech firm Coloplast’s Q1 report for 2021/2022 brings a slight upward adjustment of the reported revenue growth outlook due to foreign exchange developments. Coloplast’s acquisition of Atos Medical is expected to contribute around 6 percent to organic growth.

Demant's surgical division loses president of 13 years

Oticon Medical, the implants division at hearing group Demant, is saying goodbye to President Jes Olsen, who is exiting his role in March after having spearheaded the business leg since 2008. Demant CEO Søren Nielsen is stepping in temporarily until a replacement is found.

Hearing aid market in US grew by 37 percent in 2021

Hearing aid manufacturers have had a good year following one of the worst in their recorded history, as sales in the US have gone up by 37 percent. The progress is mainly driven by the recovery of independent retailers, whereas public sales channel Veterans Affairs still lags behind.

Further reading

Related articles

Latest news

See all jobs